BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neuron
,
Early pregnancy factor
,
Doxycycline
,
rs6983267
,
IGF1
,
HIV infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
interleukin- receptor
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Interleukins and Interleukin Receptors Evolutionary History and Origin in Relation to CD4+ T Cell Ev…
Interleukin Receptor Antagonists and Janus Kinase Inhibitors Repurposed for Treatment of COVID-19.
MicroRNA-155-5p modulates the progression of acute respiratory distress syndrome by targeting interl…
The first-in-human study of CNTO 7160, an anti-interleukin-33 receptor monoclonal antibody, in healt…
A novel target anti-interleukin-13 receptor subunit alpha-2 monoclonal antibody inhibits tumor growt…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage
GDM Patients and Serum Amyloid A and Interleukin-1 (IL-1) Receptor Antagonist
Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Patients With Hand Osteoarthritis
Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins
Effect of Interleukin 6 Receptor Antagonists in Corona Virus Disease 19 Patients Known by WHO
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ